病原性TDP-43在肌缩侧面硬化症中的病原性TDP-43
Zhao Zhong Chong1, Nizar Souayah1
1Department of Neurology, Rutgers University, New Jersey Medical School, Newark, NJ, USA.
Drug discovery today
|April 6, 2025
概括
43 kDa (TDP-43) 的异常交易反应DNA结合蛋白的表达与肌缩性侧面硬化症 (ALS) 有关. 了解TDP-43机制对于开发有效的ALS疗法至关重要.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- TDP-43的异常表达是肌缩侧面硬化症 (ALS) 的标志,在多达97%的病例中发现.
- 大脑和脊髓中TDP-43的细胞质内含是ALS特征的神经病理特征.
- 基因突变和TDP-43的翻译后修改有助于其病原性聚合.
研究的目的:
- 阐明TDP-43在ALS病原发生中的作用背后的机制.
- 通过了解与TDP-43相关的途径来确定ALS的潜在治疗点.
- 研究TDP-43功能障碍如何影响细胞过程,如自和线粒体功能.
主要方法:
- 在ALS患者组织中分析TDP-43表达模式.
- 研究TARDBP基因突变及其对TDP-43局部化和修改的影响.
- 细胞研究检查TDP-43聚合对自和线粒体完整性的影响.
主要成果:
- 在TARDBP突变促进TDP-43核出口和细胞质聚合.
- TDP-43的裂变和碎片形成与ALS的发展有关.
- 损伤的自和线粒体功能障碍是致病性TDP-43积累的后果.
结论:
- 致病性TDP-43的积累和功能障碍是ALS病变的核心.
- 了解TDP-43机制为开发新型ALS疗法提供了一个有希望的途径.
- 针对与TDP-43相关的细胞损伤途径可能会减轻ALS的神经退行.
更多相关视频
07:14Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
Published on: February 25, 2022
5.9K
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
8.7K
相关概念视频
01:15Parkinson's Disease: Overview
399
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
399
03:03Amyloid Fibrils
9.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.1K